Mumbai, December 31, 2025 Wockhardt Limited (NSE: WOCKPHARMA, BSE: 532300) shares were trading higher on Wednesday after the company announced that the European Medicines Agency has granted Accelerated Assessment status to its novel antibiotic candidate WCK 5222.At around 12:44 PM IST, Wockhardt shares were trading at ₹1,427, up ₹52.80 or 3.84 percent from the previous close, with the stock moving between an intraday high of ₹1,438.80 and a low of ₹1,373.00.EMA Grants Accelerated...